Parmax Pharma Independent Director Resigns Post Management Change

Key Event Details

Ms. Ami Shah has resigned from her position as Independent Director of Parmax Pharma Limited with effect from the closing of business hours on October 28, 2026. The resignation is specifically attributed to "change in management and control of the Company pursuant to the acquisition of a majority stake in the Company by the incoming shareholders and the completion of the open offer process in accordance with the provisions of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011."

Director Confirmation

Ms. Shah has explicitly confirmed in her resignation letter dated October 25, 2026, that "there are no material reasons for my resignation other than those stated above." She holds DIN: 08158605.

Additional Director Information

As per the annexure disclosure:

• No other listed entity directorships held by Ms. Shah (disclosed as "NIL")
• No brief profile or relationship disclosure required as this is a cessation event

Management Acknowledgement

The resignation was accepted by the company on October 28, 2026, as indicated by the notation "Accepted 28/10/26" on the resignation letter. The disclosure was signed by Umang Gosalia, Managing Director (DIN: 05153830), on October 28, 2026, at 20:39:13 IST.